CIK 0001813814 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Definium Therapeutics, Inc.
Sign in to watch- Ticker
- DFTX
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- 212-220-6633
- Business address
- ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
- Former names
- Mind Medicine (MindMed) Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,023,010
- in 6 filings, $3.0M under 10b5-1 plans
Net −$3,023,010. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Barrow Robert −$1.9M Chief Executive Officer sold 2% of stake
- Sullivan Mark −$514K Chief Legal Officer sold 3% of stake
- Karlin Daniel −$397K Chief Medical Officer sold 1% of stake
- Roberts Brandi −$123K Chief Financial Officer sold <1% of stake
- Wiley Matthew T. −$113K Chief Commercial Officer sold <1% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-25 | Karlin Daniel Chief Medical Officer | Sale 10b5-1 | −10,853 | $36.57 | $397K | 792,846 |
| 2026-09-25 | Barrow Robert Chief Executive Officer | Sale 10b5-1 | −31,550 | $36.57 | $1.2M | 2,213,090 |
| 2026-09-25 | Wiley Matthew T. Chief Commercial Officer | Sale 10b5-1 | −3,097 | $36.57 | $113K | 359,036 |
| 2026-09-25 | Sullivan Mark Chief Legal Officer | Sale 10b5-1 | −14,051 | $36.57 | $514K | 494,228 |
| 2026-09-25 | Roberts Brandi Chief Financial Officer | Sale 10b5-1 | −3,377 | $36.57 | $123K | 394,528 |
| 2026-09-03 | Barrow Robert Chief Executive Officer | Sale 10b5-1 | −19,023 | $37.94 | $722K | 1,494,640 |
| 2026-06-25 | Sullivan Mark Chief Legal Officer | Sale 10b5-1 | −13,008 | $45.03 | $586K | 320,571 |
| 2026-06-25 | Karlin Daniel Chief Medical Officer | Sale 10b5-1 | −10,035 | $45.03 | $452K | 503,282 |
| 2026-06-25 | Roberts Brandi Chief Financial Officer | Sale 10b5-1 | −3,013 | $45.03 | $136K | 209,487 |
| 2026-06-25 | Barrow Robert Chief Executive Officer | Sale 10b5-1 | −29,208 | $45.03 | $1.3M | 1,098,246 |
| 2026-06-25 | Wiley Matthew T. Chief Commercial Officer | Sale 10b5-1 | −2,867 | $45.03 | $129K | 174,633 |
| 2026-03-25 | Karlin Daniel Chief Medical Officer | Sale 10b5-1 | −8,018 | $18.47 | $148K | 413,317 |
| 2026-03-25 | Sullivan Mark Chief Legal Officer | Sale 10b5-1 | −10,702 | $18.47 | $198K | 271,079 |
| 2026-03-25 | Barrow Robert Chief Executive Officer | Sale 10b5-1 | −24,431 | $18.47 | $451K | 752,454 |
| 2025-12-26 | Karlin Daniel Chief Medical Officer | Sale 10b5-1 | −5,600 | $13.15 | $74K | 425,025 |
| 2025-12-26 | Barrow Robert Chief Executive Officer | Sale 10b5-1 | −25,791 | $13.15 | $339K | 778,477 |
| 2025-12-26 | Sullivan Mark Chief Legal Officer | Sale 10b5-1 | −11,276 | $13.15 | $148K | 282,576 |
| 2025-09-25 | Sullivan Mark Chief Legal Officer | Sale 10b5-1 | −11,278 | $9.77 | $110K | 293,852 |
| 2025-09-25 | Barrow Robert Chief Executive Officer | Sale 10b5-1 | −25,797 | $9.77 | $252K | 804,268 |
| 2025-09-25 | Karlin Daniel Chief Medical Officer | Sale 10b5-1 | −7,704 | $9.77 | $75K | 430,625 |
Page 1 of 5 · 82 trades